bbc.co.uk/news/business-421...
Two pharmaceutical firms have said they will invest more than £1bn in the UK, creating about 1,850 jobs.
MSD, known as Merck in North America, will support a new research centre in London creating around 950 new posts.
Germany's Qiagen will develop a genomics and diagnostics campus in Manchester, creating up to 800 jobs.
The government said these biotech deals illustrated confidence it its industrial strategy, the details of which it is publishing later.
“Mr Clark said the UK's decision to leave the EU meant the strategy was "even more important" “